Lung cancer
Conditions
Interventions
The thoracic analgesia group:Pleural analgesia by Ropivacaine
The intercostal analgesia group:Intercostal analgesia by Ropivacaine
The PCIA group:PCIA
The paravertebral analgesia group:Paravertebral analgesia by Ropivacaine
Sponsors
Army Medical Center of PLA
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. 18-80 years old, gender is not limited; 2. Pulmonary nodules are mainly composed of ground glass (>50%), with a diameter of <= 2cm, and thoracoscopic segmentectomy + lymph node sampling is planned; 3. Able to tolerate surgery, with good cardiopulmonary and other organ function; 4. The subjects were able to read and fully understand the relevant contents of the informed consent form, and signed the informed consent form at the same time.
Exclusion criteria
Exclusion criteria: 1. Allergy to ropivacaine; 2. It is planned to perform multiple segmentectomy or combined lobectomy at the same time; 3. The lesions are dominated by solid components, or the possibility of invasive lung cancer is considered; 4. Patients with previous history of tuberculous pleurisy or thoracic surgery on the same side of surgery, considering extensive adhesion of the pleural cavity; 5. Liver and kidney insufficiency; 6. Refused to participate in clinical trials; 7. Severe hypertension or other contraindications to flurbiprofen use.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain Visual Scale Score;Postoperative complications; | — |
Secondary
| Measure | Time frame |
|---|---|
| Leukocyte;Thoracic drainage volume;Interleukin-6;Number of pain medication used;The removal time of Drainage tube; | — |
Countries
China
Contacts
Public ContactMeng Shenglan
Army Medical Center of PLA
Outcome results
None listed